Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idex (IEX) EBITDA (2016 - 2025)

Idex (IEX) has disclosed EBITDA for 17 consecutive years, with $183.6 million as the latest value for Q4 2025.

  • Quarterly EBITDA rose 11.07% to $183.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $699.3 million through Dec 2025, up 3.26% year-over-year, with the annual reading at $699.3 million for FY2025, 3.26% up from the prior year.
  • EBITDA for Q4 2025 was $183.6 million at Idex, down from $185.8 million in the prior quarter.
  • The five-year high for EBITDA was $202.2 million in Q3 2022, with the low at $142.0 million in Q1 2025.
  • Average EBITDA over 5 years is $174.9 million, with a median of $177.3 million recorded in 2022.
  • The sharpest move saw EBITDA surged 43.14% in 2021, then fell 16.17% in 2024.
  • Over 5 years, EBITDA stood at $162.0 million in 2021, then increased by 8.02% to $175.0 million in 2022, then dropped by 8.29% to $160.5 million in 2023, then grew by 2.99% to $165.3 million in 2024, then grew by 11.07% to $183.6 million in 2025.
  • According to Business Quant data, EBITDA over the past three periods came in at $183.6 million, $185.8 million, and $187.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.